Valneva signs purchase agreement with european commission for its inactivated covid-19 vaccine vla2001

Saint- herb lain (france ) , november 23 , 2021 – valneva se (nasdaq: valn; euronext paris: vla), a specialty vaccine company, today announced that it has signed an advance purchase agreement (apa) with the european commission (ec) to supply up to 60 million doses of its inactivated covid-19 vaccine candidate, vla2001, over two years. the agreement follows the announcement made earlier this month that the ec had approved the apa1.
VALN Ratings Summary
VALN Quant Ranking